O
Oxyle
Provides a novel wastewater treatment that completely eliminates the most persistent and toxic micropollutant
About Oxyle
Oxyle is a Swiss-based startup that operates in the environmental technology sector, specifically focusing on the removal of micropollutants from water resources. Micropollutants are a broad category of organic pollutants that are released from everyday products such as pharmaceuticals, pesticides, and personal care products. These pollutants are non-biodegradable, bio-active, carcinogenic, and toxic, posing significant risks to humans and ecosystems even at very low concentrations.
Oxyle's primary clients are likely to be entities responsible for water treatment, including municipalities, industries, and possibly even private households. The company's business model revolves around providing a sustainable and cost-effective solution to the global problem of micropollution. By removing a large proportion of micropollutants from wastewater, Oxyle helps to protect water resources, humans, and the environment.
The company generates revenue by selling its unique technology that efficiently treats wastewater to remove micropollutants. This technology is crucial as untreated wastewater containing micropollutants can contaminate rivers, lakes, groundwater, and even drinking water.
In summary, Oxyle is a promising startup that offers a sustainable and efficient solution to the global micropollution problem, serving a market that includes municipalities, industries, and households.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2020
- Headquarters
- Schlieren, Switzerland
- Employees
- 42
- Open positions
- None listed
- Dealroom signal
- 83.5/100
- Sub-industry
- Water, Waste Solution
- Sector
- Energy, Water Treatment, Spinout, Sustainable Development Goals, EIC, Wastewater Treatment, Climate Tech, Blue Economy, Water Tech
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEED✓Equity / VC | Jan 2025 | $16M | $64M | Founderful · SOSV · Axeleo Capital · 360 Capital | ↗ |
| SEED✓Equity / VC | Dec 2022 | $2.6M | $10M | SOSV · Better Ventures · Founderful · another.vc | ↗ |
Growth signals
Latest recorded traffic for Oxyle is 3.8K monthly website visits, down 62% over the last three months. Oxyle's team grew 13.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed8 investors entered at this stage
venture.ch Award
European Innovation Council
SOSV
Better Ventures
Founderful
another.vc
360 Capital
Axeleo Capital
Other known investors4 additional known investors
ETH Zurich
MassChallenge
UpLink - World Economic Forum
Venture Kick
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Oxyle on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Oxyle’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.